94 related articles for article (PubMed ID: 29389085)
21. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
[TBL] [Abstract][Full Text] [Related]
22. Horner syndrome in a newly diagnosed patient with high risk precursor B-cell acute lymphoblastic leukemia.
Fountaine TJ; Miller B; Khalifa YM; Andolina JR
Pediatr Blood Cancer; 2012 Aug; 59(2):344. PubMed ID: 22232083
[No Abstract] [Full Text] [Related]
23. B-cell precursor acute lymphoblastic leukemia with isolated t(14;19)(q32;q13) abnormality involving the CEBPG gene.
Haghi N; Brody J; Mahmood N; Gheewala D; Allen SL; Sreekantaiah C; Zhang X
Leuk Lymphoma; 2015; 56(10):2978-81. PubMed ID: 25669928
[No Abstract] [Full Text] [Related]
24. [Treatment of chronic lymphocytic leukemia and NK-cell leukemia/lymphoma].
Sugimoto K; Oshimi K
Nihon Rinsho; 2007 Jan; 65 Suppl 1():569-74. PubMed ID: 17476757
[No Abstract] [Full Text] [Related]
25. The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia.
Wang W; Gao L; Li Y; Li ZL; Gong M; Huang FZ; Chen YR; Zhang CX; Gao YY; Ma YG
Leuk Lymphoma; 2016 May; 57(5):1174-81. PubMed ID: 26436205
[TBL] [Abstract][Full Text] [Related]
26. [Expression of CD123 in lymphocytic leukemia and its significance for monitoring minimal residual diseases.].
Wang YF; Chen BG; Luo WD; Zheng R; Li BL
Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):244-8. PubMed ID: 20510041
[TBL] [Abstract][Full Text] [Related]
27. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
28. Potent induction of apoptosis by givinostat in BCR-ABL1-positive and BCR-ABL1-negative precursor B-cell acute lymphoblastic leukemia cell lines.
Yao C; Zhang G; Walker A; Zhao KY; Li Y; Lyu L; Tang Y; Ru P; Jones D; Zhao W
Leuk Res; 2017 Sep; 60():129-134. PubMed ID: 28818808
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-21 and rituximab enhance NK cell functionality in patients with B-cell chronic lymphocytic leukaemia.
Eskelund CW; Nederby L; Thysen AH; Skovbo A; Roug AS; Hokland ME
Leuk Res; 2011 Jul; 35(7):914-20. PubMed ID: 21354618
[TBL] [Abstract][Full Text] [Related]
30. CD5-positive acute lymphoblastic leukemia.
Ahmed D; Ahmed TA; Ahmed S; Tipu HN; Wiqar MA
J Coll Physicians Surg Pak; 2008 May; 18(5):310-1. PubMed ID: 18541090
[TBL] [Abstract][Full Text] [Related]
31. Pure erythroid leukemia following precursor B-cell lymphoblastic leukemia.
Xu M; Finn LS; Tsuchiya KD; Thomson B; Pollard J; Rutledge J
Pediatr Dev Pathol; 2012; 15(1):76-8. PubMed ID: 21877942
[TBL] [Abstract][Full Text] [Related]
32. How would I manage a sample submitted for flow cytometry analysis for suspicious chronic lymphocytic leukaemia.
Bulian P; Del Poeta G; Gattei V
Hematol Oncol; 2009 Dec; 27(4):186-9. PubMed ID: 19569256
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
34. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Kawada J; Ito Y; Iwata S; Suzuki M; Kawano Y; Kanazawa T; Siddiquey MN; Kimura H
Clin Cancer Res; 2014 Nov; 20(21):5412-22. PubMed ID: 25208880
[TBL] [Abstract][Full Text] [Related]
35. CD317 is over-expressed in B-cell chronic lymphocytic leukemia, but not B-cell acute lymphoblastic leukemia.
Gong S; Osei ES; Kaplan D; Chen YH; Meyerson H
Int J Clin Exp Pathol; 2015; 8(2):1613-21. PubMed ID: 25973046
[TBL] [Abstract][Full Text] [Related]
36. The web of microRNA in B lymphoblastic leukemia.
Gurbuxani S
Leuk Lymphoma; 2017 Sep; 58(9):2024-2025. PubMed ID: 28632459
[No Abstract] [Full Text] [Related]
37. Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.
Tsitsikov E; Harris MH; Silverman LB; Sallan SE; Weinberg OK
Int J Lab Hematol; 2018 Jun; 40(3):343-351. PubMed ID: 29500862
[TBL] [Abstract][Full Text] [Related]
38. A childhood acute lymphoblastic leukemia-specific lncRNA implicated in prednisolone resistance, cell proliferation, and migration.
Ouimet M; Drouin S; Lajoie M; Caron M; St-Onge P; Gioia R; Richer C; Sinnett D
Oncotarget; 2017 Jan; 8(5):7477-7488. PubMed ID: 27980230
[TBL] [Abstract][Full Text] [Related]
39. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied.
Wilhelm C; Neubauer A; Brendel C
Cytometry B Clin Cytom; 2006 Jul; 70(4):242-50. PubMed ID: 16906574
[TBL] [Abstract][Full Text] [Related]
40. NCCN: Non-Hodgkin's lymphoma.
Zelenetz AD; Hoppe RT;
Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
